Volpara takeover by Lunit gets tick from Grant Samuel

Volpara takeover by Lunit gets tick from Grant Samuel
A technician uses Volpara's system to screen for breast cancer. (Image: Getty)
Pattrick Smellie
Directors in Wellington-headquartered health-tech firm Volpara are recommending shareholders accept a 100% takeover bid from a Korean-listed counterpart after a favourable independent valuation.ASX-listed Volpara was judged by independent valuer Grant Samuel to be worth between A67c (72c) and A82c per share, compared with the takeover from Seoul-based Lunit pitched at A$1.15.The offer represented a 47% premium to the A87cps that Volpara was trading at before the Lunit bid on Dec 14, and 55% above the weighted average share price in the month be...

More Markets

NZX gains 0.3% on busy day of earnings
Markets Market close

NZX gains 0.3% on busy day of earnings

Seven companies reported on Monday.

Gregor Thompson 25 Aug 2025
Kogan.com takes $51m goodwill hit on Mighty Ape
Retail

Kogan.com takes $51m goodwill hit on Mighty Ape

Kogan.com has written down A$46.3 million (NZ$51.2m) of goodwill tied to its New Zealand segment, Mighty Ape.  The Australian retail and services group filed its earnings for the 12 months to June 30 with the Australian Securities Exchange (ASX) on Monday.Chief executive Ruslan K...

Staff reporters 25 Aug 2025
PFI boss expects NTA discount to close
Property

PFI boss expects NTA discount to close

Property for industry is trading at a 50-cent discount to the net value of its assets.

Gregor Thompson 25 Aug 2025